Publication
Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
| dc.contributor.author | Carvalho, D | |
| dc.contributor.author | Russo, P | |
| dc.contributor.author | Bernardes, C | |
| dc.contributor.author | Saiote, J | |
| dc.contributor.author | Ramos, G | |
| dc.contributor.author | Mascarenhas, L | |
| dc.contributor.author | Borges, N | |
| dc.contributor.author | Ramos, J | |
| dc.date.accessioned | 2018-03-06T15:52:57Z | |
| dc.date.available | 2018-03-06T15:52:57Z | |
| dc.date.issued | 2017-11 | |
| dc.description.abstract | INTRODUCTION: Lymphoproliferative disorders, particularly non-Hodgkin's and Hodgkin's lymphomas, are rare in patients with inflammatory bowel diseases. The use of thiopurines and infection by Epstein-Barr virus are well-known cofactors that can raise its prevalence. Other risk factors such as disease activity and biological treatment are the subject of discussion, without enough data in the literature to confirm a potential association. METHODS: We report a case of Hodgkin's lymphoma in a patient who had been treated with azathioprine and was on long-term monotherapy with infliximab. CONCLUSIONS: We stress the importance of recognizing the possible occurrence of a lymphoproliferative disorder in association with anti-tumor necrosis factor-α therapy. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | GE Port J Gastroenterol. 2017 Nov;24(6):279-284. | pt_PT |
| dc.identifier.doi | 10.1159/000455180 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.17/2930 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Sociedade Portuguesa de Gastrenterologia | pt_PT |
| dc.subject | CHLC GAS | pt_PT |
| dc.subject | CHLC PAT CLIN | pt_PT |
| dc.subject | CHLC CIR | pt_PT |
| dc.subject | Crohn's Disease | pt_PT |
| dc.subject | Hodgkin's Disease/Chemically Induced | pt_PT |
| dc.subject | Infliximab | pt_PT |
| dc.subject | Lymphoproliferative Disorders | pt_PT |
| dc.subject | Tumor necrosis factor-α | pt_PT |
| dc.title | Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab | pt_PT |
| dc.title.alternative | Linfoma de Hodgkin em Doença de Crohn Medicada com Infliximab | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 284 | pt_PT |
| oaire.citation.issue | 6 | pt_PT |
| oaire.citation.startPage | 279 | pt_PT |
| oaire.citation.title | GE - Portuguese Journal of Gastroenterology | pt_PT |
| oaire.citation.volume | 24 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |